Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
Masahiko Ayaki1, Atsuo Iwasawa2, Yoichi Inoue31Department of Ophthalmology, Saitama National Hospital, Wako, Japan; 2Life Particle Interaction Engineering Creation, New Industry Creation Hatchery Center, Tohoku University, Sendai, Japan; 3Department of Ophthalmology, Olympia Eye Hospital, Tokyo, Jap...
Guardado en:
Autores principales: | Masahiko Ayaki, Atsuo Iwasawa, Yoichi Inoue |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f15638284e574c5aad17574944148cd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
por: Masahiko Ayaki, et al.
Publicado: (2010) -
Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines
por: Masahiko Ayaki, et al.
Publicado: (2010) -
Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications
por: Meloni M, et al.
Publicado: (2012) -
Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
por: Rosin LM, et al.
Publicado: (2013) -
Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo J, et al.
Publicado: (2016)